Seattle Genetics, Inc. (NASDAQ:SGEN) went lower by -0.27% to close at $ 44.78. The company exchanged total volume of 526.2 thousand shares throughout course of last trade however it holds an average trading capacity of 718.64 thousand shares. Shares of company began trading at $45.14 climbed to high of $45.14 touched the low of $44.03.
The company is trading below its 50-day moving averages of 45.81 and up from 200-day moving averages of 38.97. The firm has price to book ratio of 9.43 and its price to sale ratio was 16.43.
According to ZACKS data, different Brokerage Firms rated the stock about their BUY, SELL or HOLD recommendations. One week ago, shares have been suggested as “BUY” from “1” brokerage firms and recommended as “Strong Buy” by “4” brokerage firms. 0” brokerage firms have issued “Sell” rating for the company and “Strong Sell” rating was issued by “0” brokerage firms. “5” brokerage firms have rated the company as a “Hold”. The Corporation has average brokerage recommendation (ABR) of 2.1 based on consensus of the brokerage firms issuing ratings.
The average true range of Seattle Genetics, Inc.’s (SGEN) is recorded at 1.51 and the relative strength index of the stock stands 47.58. The stock price is going above to its 52 week low with 72.10% and lagging behind from its 52 week high with -9.83%. Analyst recommendation for this stock stands at 2.50. A look on the firm performance, its monthly performance is -6.77% and a quarterly performance of 2.75%. The stock price is trading upbeat from its 200 days moving average with 15.28% and up from 50 days moving average with 1.28%.
Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) surged +0.3541% and closed the trade at $ 0.3401. The company recorded a trading capacity of 425.76 thousand shares below its three months average daily volume of 899.86 thousand shares. During the last trade, shares reached to high price of $0.3500 and touched the low price of $0.3346. The stock’s 50-day moving average is noted at $0.4172 and its 200-day moving average is stands at $1.0220.
Additionally, the company has EPS of -0.2660. The company has market capitalization of $38.68M.
Northwest Biotherapeutics, Inc.’s (NWBO) has price-to-cash ratio of 19.01 and price to sale ratio of 26.62. A look on the firm performance, its monthly performance is -26.07% and a quarterly performance of -58.07%. The stock price is moving down from its 20 days moving average with -11.08% and isolated negatively from 50 days moving average with -25.76%.